Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, January 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 149 articles:
HTML format


 

Single Articles

  1. YANG L, Cao J, Ma J, Li M, et al
    Differences in the microcirculation disturbance in the right and left ventricles of neonatal rats with hypoxic pulmonary hypertension.
    Microvasc Res. 2020 Dec 29:104129. doi: 10.1016/j.mvr.2020.104129.
    PubMed    
    Abstract available

  2. CHIBA Y, Iwano H, Murayama M, Kaga S, et al
    Presence and relevance of mid-systolic notching on right ventricular outflow tract flow velocity envelopes in pulmonary hypertension due to heart failure.
    J Am Soc Echocardiogr. 2020 Dec 28. pii: S0894-7317(20)30812.
    PubMed    


  3. EBATA R, Fujioka T, Diab SG, Pieles G, et al
    Asymmetric Regional Work Contributes to Right Ventricular Fibrosis, Inefficiency and Dysfunction in Pulmonary Hypertension versus Regurgitation.
    J Am Soc Echocardiogr. 2020 Dec 28. pii: S0894-7317(20)30805.
    PubMed    
    Abstract available

  4. EROL C
    New year and our 20th Anniversary, Thomas F. Luscher, pulmonary hypertension.
    Anatol J Cardiol. 2021;25:1.
    PubMed    


  5. KAPTAN OZEN D, Mutlu B, Kocakaya D, Turan B, et al
    Pulmonary hypertension in patients with sarcoidosis: A single-center experience.
    Anatol J Cardiol. 2021;25:36-41.
    PubMed    
    Abstract available

  6. SAHUTOGLU E, Tuncay E, Aras G, Yenturk E, et al
    Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism.
    Anatol J Cardiol. 2021;25:24-29.
    PubMed    
    Abstract available

  7. SARI A, Sener YZ, Armagan B, Kilic L, et al
    How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
    Anatol J Cardiol. 2021;25:30-35.
    PubMed    
    Abstract available

  8. SEGEL MJ, Somech D, Lang IM, Segev A, et al
    Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: First Experience at the Israeli National CTEPH Referral Center.
    Isr Med Assoc J. 2020;22:752-756.
    PubMed    
    Abstract available

  9. ALHAMAD EH, Cal JG
    Predictors of mortality in interstitial lung disease patients without pulmonary hypertension.
    Ann Thorac Med. 2020;15:238-243.
    PubMed    
    Abstract available

  10. ALBANAQI AL, Rahimi GRM, Smart NA
    Exercise Training for Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Biol Res Nurs. 2020 Dec 29:1099800420982376. doi: 10.1177/1099800420982376.
    PubMed    
    Abstract available

  11. GRUNIG E, Eichstaedt CA, Seeger R, Benjamin N, et al
    Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis.
    Diagnostics (Basel). 2020;10.
    PubMed    
    Abstract available

  12. MAHAJAN S, Mehra P, Mehta V, Yusuf J, et al
    Left and right ventricular deformation in patients with severe mitral stenosis and pulmonary hypertension undergoing percutaneous balloon mitral valvuloplasty: A two dimensional speckle-tracking echocardiographic study.
    Indian Heart J. 2020;72:614-618.
    PubMed    
    Abstract available

  13. MEDVEDEV R, Sanchez-Alonso JL, Alvarez-Laviada A, Rossi S, et al
    Nanoscale Study of Calcium Handling Remodeling in Right Ventricular Cardiomyocytes Following Pulmonary Hypertension.
    Hypertension. 2020 Dec 28:HYPERTENSIONAHA12014858.
    PubMed    
    Abstract available

  14. WANG D, Zhu ZL, Lin DC, Zheng SY, et al
    Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters.
    Hypertension. 2020 Dec 28:HYPERTENSIONAHA12014909.
    PubMed    
    Abstract available

  15. ALKHUNAIZI FA, Harowicz MR, Ireland CG, Houston BA, et al
    Kussmaul's Sign in Pulmonary Hypertension Corresponds With Severe Pulmonary Vascular Pathology Rather Than Right Ventricular Diastolic Dysfunction.
    Circ Heart Fail. 2020 Dec 28:CIRCHEARTFAILURE120007461.
    PubMed    


  16. BABU AS, Morris NR
    Patients support exercise training and rehabilitation-what more should we be doing to ensure cardiopulmonary rehabilitation is more readily available for those with pulmonary hypertension?
    Pulm Circ. 2020;10:2045894020975312.
    PubMed    


  17. DAS BB
    COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
    Medicina (Kaunas). 2020;56.
    PubMed    
    Abstract available

  18. KOJONAZAROV B
    Heart Rate Reduction by Ivabradine: Slowly but Surely?
    Am J Respir Cell Mol Biol. 2020;63:725-726.
    PubMed    


  19. ZHAO QH, Peng FH, Yu ZX, Zhang GC, et al
    Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther. 2020;18:643-649.
    PubMed    
    Abstract available

  20. YILMAZEL UCAR E, Donkar B, Araz O, Akgun M, et al
    A massive pulmonary thromboembolism after pulmonary endarterectomy: A case report.
    Tuberk Toraks. 2020;68:76-79.
    PubMed    
    Abstract available

  21. SEIMETZ M, Sommer N, Bednorz M, Pak O, et al
    NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
    Nat Metab. 2020;2:532-546.
    PubMed    
    Abstract available

  22. VERBRUGGE FH, Borlaug BA
    Getting the "Right" Perspective on Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.
    J Am Heart Assoc. 2020;9:e017292.
    PubMed    


  23. ASHRAF H, Rosenthal JL
    Right Heart Failure: Causes and Clinical Epidemiology.
    Cardiol Clin. 2020;38:175-183.
    PubMed    
    Abstract available

  24. LYSDAHLGAARD S, Hess S, Gerke O, Weber Kusk M, et al
    A systematic literature review and meta-analysis of spectral CT compared to scintigraphy in the diagnosis of acute and chronic pulmonary embolisms.
    Eur Radiol. 2020 Feb 28. pii: 10.1007/s00330-020-06735.
    PubMed    
    Abstract available

  25. KESHAVARZ A, Kadry H, Alobaida A, Ahsan F, et al
    Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.
    Expert Opin Drug Deliv. 2020;17:439-461.
    PubMed    
    Abstract available

  26. TURCK P, Fraga S, Salvador I, Campos-Carraro C, et al
    Blueberry extract decreases oxidative stress and improves functional parameters in lungs from rats with pulmonary arterial hypertension.
    Nutrition. 2020;70:110579.
    PubMed    
    Abstract available

  27. LIN K, Sarnari R, Pathrose A, Gordon D, et al
    Cine MRI detects elevated left heart pressure in pulmonary hypertension.
    J Magn Reson Imaging. 2021 Jan 9. doi: 10.1002/jmri.27504.
    PubMed    
    Abstract available

  28. FLORENTIN J, Zhao J, Tai YY, Vasamsetti SB, et al
    Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension.
    Cell Mol Immunol. 2021 Jan 8. pii: 10.1038/s41423-020-00608.
    PubMed    
    Abstract available

  29. SANADA TJ, Sun XQ, Happe C, Guignabert C, et al
    Altered TGFbeta/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention.
    Cells. 2021;10.
    PubMed    
    Abstract available

  30. CHONG T, Park J, Aslam HM, Ansari S, et al
    Pulmonary Tumor Embolism: A Rare Cause of Acute Pulmonary Hypertension.
    Cureus. 2020;12:e11877.
    PubMed    
    Abstract available

  31. TIAN H, Liu L, Wu Y, Wang R, et al
    Resistin-like molecule beta acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca(2+)-dependent PI3K/Akt/mTOR and PKC/MAPK signaling pathways.
    Respir Res. 2021;22:8.
    PubMed    
    Abstract available

  32. PINELLO G, Geraci L, Rinaudo G, Rosella V, et al
    An unusual neonatal case of reverse flow in the aortic arch and persistent pulmonary hypertension.
    Echocardiography. 2021 Jan 5. doi: 10.1111/echo.14928.
    PubMed    
    Abstract available

  33. KOKKINIDIS DG, Archontakis-Barakakis P
    Pulmonary Hypertension in Patients with Aortic Stenosis.
    Trends Cardiovasc Med. 2021 Jan 2. pii: S1050-1738(20)30170.
    PubMed    


  34. FRANK BS, Schafer M, Thomas TM, Ivy DD, et al
    Longitudinal assessment of right atrial conduit fraction provides additional insight to predict adverse events in pediatric pulmonary hypertension.
    Int J Cardiol. 2021 Jan 2. pii: S0167-5273(20)34321.
    PubMed    
    Abstract available

  35. REMY-JARDIN M, Ryerson CJ, Schiebler ML, Leung ANC, et al
    Imaging of Pulmonary Hypertension in Adults: A Position Paper from the Fleischner Society.
    Radiology. 2021 Jan 5:203108. doi: 10.1148/radiol.2020203108.
    PubMed    
    Abstract available

  36. BERMEJO J, Gonzalez-Mansilla A, Mombiela T, Fernandez AI, et al
    Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival.
    J Am Heart Assoc. 2021 Jan 5:e019949. doi: 10.1161/JAHA.120.019949.
    PubMed    
    Abstract available

  37. MEINEL K, Koestenberger M, Sallmon H, Hansmann G, et al
    Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young.
    Diagnostics (Basel). 2020;11.
    PubMed    
    Abstract available

  38. SUZUKI K, Kanamoto M, Hinohara H, Saito S, et al
    A Case of Hypopituitarism Complicated by Non-Alcoholic Steatohepatitis and Severe Pulmonary Hypertension.
    Am J Case Rep. 2021;22:e928004.
    PubMed    
    Abstract available

  39. DURAN A, Mandras S
    Pulmonary hypertension in heart failure.
    Curr Opin Cardiol. 2020;Publish Ahead of Print.
    PubMed    
    Abstract available

  40. ZHOU MY, Cheng L, Chen L, Gu YJ, et al
    Calcium-sensing receptor in the development and treatment of pulmonary hypertension.
    Mol Biol Rep. 2021 Jan 4. pii: 10.1007/s11033-020-06065.
    PubMed    
    Abstract available

  41. ASL FALLAH S, Ghodsi S, Soleimani H, Mohebi M, et al
    Incidence and predictors of chronic thromboembolic pulmonary hypertension following first episode of acute pulmonary embolism.
    Adv Respir Med. 2020;88:539-547.
    PubMed    
    Abstract available

  42. RROJI M, Cafka M, Seferi S, Seiti J, et al
    The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients.
    Int Urol Nephrol. 2021 Jan 3. pii: 10.1007/s11255-020-02655.
    PubMed    
    Abstract available

  43. DAWADI S, Basyal B, Subedi Y
    Morbidity Among Athletes Presenting for Medical Care During 3 Iterations of an Ultratrail Race in the Himalayas.
    Wilderness Environ Med. 2020;31:437-440.
    PubMed    
    Abstract available

  44. HU L, Li L, Chang Q, Fu S, et al
    Discovery of Novel Pyrazolo[3,4-b] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
    J Med Chem. 2020;63:11215-11234.
    PubMed    
    Abstract available

  45. NAIR A
    Pharmacologic therapy for pulmonary artery hypertension.
    Curr Opin Cardiol. 2020;35:643-656.
    PubMed    
    Abstract available

  46. HESH CA, Gill AE, Soler Rodriguez D, Clifton MS, et al
    Percutaneous image-guided microwave ablation as primary therapy for PRETEXT II hepatoblastoma.
    Pediatr Blood Cancer. 2020;67:e28641.
    PubMed    


  47. ALMODOVAR S, Wade BE, Porter KM, Smith JM, et al
    HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.
    Sci Rep. 2020;10:11696.
    PubMed    
    Abstract available

  48. LANG IM, Binder T
    Right atrial strain is a surrogate of coupling in the right heart.
    Eur Heart J Cardiovasc Imaging. 2020;21:863-864.
    PubMed    


  49. BELL RD, White RJ, Garcia-Hernandez ML, Wu E, et al
    Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Arthritis Rheumatol. 2020;72:1759-1770.
    PubMed    
    Abstract available

  50. CASSAR MP, Balkhausen K
    Transient global amnesia following transoesophageal echocardiography.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  51. WANG Y, Zhong B, Wu Q, Tong J, et al
    Effect of Aldosterone on Senescence and Proliferation Inhibition of Endothelial Progenitor Cells Induced by Sirtuin 1 (SIRT1) in Pulmonary Arterial Hypertension.
    Med Sci Monit. 2020;26:e920678.
    PubMed    
    Abstract available

  52. RAY N, Gibbs MA, Littmann L
    Left or Right? When Diffuse T-Wave Inversion Is Worse Than Coronary Ischemia.
    Am J Med. 2020;133:1418-1420.
    PubMed    


  53. LV T, Yang F, Zhang K, Lv M, et al
    The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis.
    Int Immunopharmacol. 2020;81:106282.
    PubMed    
    Abstract available

  54. FAN J, Fan X, Guang H, Shan X, et al
    Upregulation of miR-335-3p by NF-kappaB Transcriptional Regulation Contributes to the Induction of Pulmonary Arterial Hypertension via APJ during Hypoxia.
    Int J Biol Sci. 2020;16:515-528.
    PubMed    
    Abstract available

  55. LI Y, Chen X, Zeng X, Chen S, et al
    Galectin-3 mediates pulmonary vascular endothelial cell dynamics via TRPC1/4 under acute hypoxia.
    J Biochem Mol Toxicol. 2020;34:e22463.
    PubMed    
    Abstract available

  56. CHOUVARINE P, Geldner J, Giagnorio R, Legchenko E, et al
    Trans-Right-Ventricle and Transpulmonary MicroRNA Gradients in Human Pulmonary Arterial Hypertension.
    Pediatr Crit Care Med. 2020;21:340-349.
    PubMed    
    Abstract available

  57. WANG Y, Duo D, Yan Y, He R, et al
    Extract of Salvia przewalskii Repair Tissue Damage in Chronic Hypoxia Maybe through the RhoA-ROCK Signalling Pathway.
    Biol Pharm Bull. 2020;43:432-439.
    PubMed    
    Abstract available

  58. URBINA-VAZQUEZ A, Lopez-Rodriguez MDC, Ortega-Silva S, Criales-Vera S, et al
    Multimodality imaging of the anomalous origin of the right pulmonary artery from the ascending aorta in an adult (hemitruncus arteriosus).
    J Cardiovasc Comput Tomogr. 2020;14:e89-e92.
    PubMed    
    Abstract available

  59. WU D, Dasgupta A, Read AD, Bentley RET, et al
    Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.
    Free Radic Biol Med. 2021 Jan 12. pii: S0891-5849(21)00001.
    PubMed    
    Abstract available

  60. IKEDA S, Kumar S
    Ventricular septal defect concomitant with patent ductal arteriosus complicated with pulmonary hypertension in adulthood.
    J Card Surg. 2020;35:2359-2360.
    PubMed    


  61. CAO Y, Wang A, Wei R, Zhang Y, et al
    An unexpected cause of pulmonary hypertension.
    Eur Heart J Case Rep. 2020;4:1-2.
    PubMed    


  62. TAMURA Y, Kumamaru H, Abe K, Satoh T, et al
    Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR).
    BMC Pulm Med. 2021;21:28.
    PubMed    
    Abstract available

  63. AZPIRI-LOPEZ JR, Galarza-Delgado DA, Colunga-Pedraza IJ, Arvizu-Rivera RI, et al
    Echocardiographic evaluation of pulmonary hypertension, right ventricular function, and right ventricular-pulmonary arterial coupling in patients with rheumatoid arthritis.
    Clin Rheumatol. 2021 Jan 14. pii: 10.1007/s10067-020-05544.
    PubMed    
    Abstract available

  64. OZGUVEN S, Ones T, Bozkurtlar E, Yanartas M, et al
    Chronic thromboembolic pulmonary hypertension: evaluation of V/Q SPECT/CT and V/Q Quotient SPECT findings with postoperative results of pulmonary endarterectomy.
    Nucl Med Commun. 2021 Jan 11. pii: 00006231-900000000-98094.
    PubMed    
    Abstract available

  65. GAREKAR S, Meeran T, Dhake S, Malankar D, et al
    Valved reverse Potts shunt in a case of pulmonary hypertension due to pulmonary veno-occlusive disease.
    Indian J Thorac Cardiovasc Surg. 2021;37:89-92.
    PubMed    
    Abstract available

  66. KURAKULA K, Smolders VFED, Tura-Ceide O, Jukema JW, et al
    Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
    Biomedicines. 2021;9.
    PubMed    
    Abstract available

  67. TUDORAN C, Tudoran M, Lazureanu VE, Marinescu AR, et al
    Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available


  68. Role of microRNA-130a in the pathogeneses of obstructive sleep apnea hypopnea syndromeassociated pulmonary hypertension by targeting the GAX gene: Retraction.
    Medicine (Baltimore). 2021;100:e24258.
    PubMed    


  69. GAO C, Liu J, Zhang R, Zhao M, et al
    The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.
    Medicine (Baltimore). 2021;100:e23896.
    PubMed    


  70. SINGH A, Siddiqui MT, Al-Yaman W, Garg R, et al
    Utility of Endoscopy in Hospitalized Patients with Gastrointestinal Hemorrhage and Pulmonary Hypertension.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06803.
    PubMed    
    Abstract available

  71. VERHEIJEN DBH, Meijer FMM, Kies P, Egorova AD, et al
    Pulmonary hypertension causing left main coronary artery compression.
    Eur Heart J Case Rep. 2020;4:1-3.
    PubMed    


  72. SAKARIN S, Surachetpong SD, Rungsipipat A
    The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
    Front Vet Sci. 2020;7:612130.
    PubMed    
    Abstract available

  73. ZHAI ZG, Xiong CM, Wang C
    [Strengthening multidisciplinary collaboration and promoting the construction of standardized system for pulmonary hypertension in China].
    Zhonghua Yi Xue Za Zhi. 2021;101:7-10.
    PubMed    
    Abstract available

  74. MOGHADDAM N, Swiston JR, Tsang MY, Levy R, et al
    IMPACT OF TARGETED PULMONARY ARTERIAL HYPERTENSION THERAPY IN PATIENTS WITH COMBINED POST- AND PRE-CAPILLARY PULMONARY HYPERTENSION.
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00005.
    PubMed    
    Abstract available

  75. LIN JJ, Zhang T, Peng M, Shi JH, et al
    [Clinical features of pulmonary artery involvement in Takayasu's arteritis and recent advances].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:54-59.
    PubMed    


  76. DHAWAN RT, Gopalan D, Howard L, Vicente A, et al
    Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19.
    Lancet Respir Med. 2020 Nov 17. pii: S2213-2600(20)30407.
    PubMed    
    Abstract available

  77. RAJABI S, Najafipour H, Jafarinejad Farsangi S, Joukar S, et al
    Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway.
    BMC Complement Med Ther. 2020;20:218.
    PubMed    
    Abstract available

  78. MONROE MN, Zhaorigetu S, Gupta VS, Jin D, et al
    Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2020 Jun 22. doi: 10.1002/ppul.24914.
    PubMed    
    Abstract available

  79. SEHGAL A, Steenhorst JJ, Mclennan DI, Merkus D, et al
    The Left Heart, Systemic Circulation, and Bronchopulmonary Dysplasia: Relevance to Pathophysiology and Therapeutics.
    J Pediatr. 2020;225:13-22.
    PubMed    


  80. HAARMAN MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, Breeman KTN, et al
    The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
    J Pediatr. 2020;225:65-73.
    PubMed    
    Abstract available

  81. JENY F, Uzunhan Y, Lacroix M, Gille T, et al
    Predictors of mortality in fibrosing pulmonary sarcoidosis.
    Respir Med. 2020;169:105997.
    PubMed    
    Abstract available

  82. KEMAL HS, Kayikcioglu M, Nalbantgil S, Can LH, et al
    Assessment of right ventricular function in patients with pulmonary arterial hypertension-congenital heart disease and repaired and unrepaired defects: Correlation among speckle tracking, conventional echocardiography, and clinical parameters.
    Anatol J Cardiol. 2020;23:277-287.
    PubMed    
    Abstract available

  83. WANG L, Xiong C, Li M, Zeng X, et al
    Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
    Ann Nucl Med. 2020 Apr 20. pii: 10.1007/s12149-020-01461.
    PubMed    
    Abstract available

  84. NUCHE J, Palomino-Doza J, Ynsaurriaga FA, Delgado JF, et al
    Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  85. DA RE JML
    Case 3: A Newborn with a Mass on the Right Ventricle.
    Neoreviews. 2020;21:e199-e202.
    PubMed    


  86. GIEN J, Nuxoll C, Kinsella JP
    Inhaled Nitric Oxide in Emergency Medical Transport of the Newborn.
    Neoreviews. 2020;21:e157-e164.
    PubMed    
    Abstract available

  87. GUO K, Xu L, Jin L, Wang H, et al
    Bone morphogenetic protein 9, and its genetic variants contribute to susceptibility of idiopathic pulmonary arterial hypertension.
    Aging (Albany NY). 2020;12:2123-2131.
    PubMed    
    Abstract available

  88. KNAFL D, Gerges C, King CH, Humbert M, et al
    Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.
    Eur Respir Rev. 2020;29.
    PubMed    
    Abstract available

  89. HAGHBAYAN H, Coomes EA, Gunaratne K
    A Man in His 40s With Coronary-to-Pulmonary Artery Collateralizations.
    JAMA Cardiol. 2020;5:356.
    PubMed    


  90. PARADIES P, Sasanelli M, Capogna A, Mercadante A, et al
    Is Pulmonary Hypertension a Rare Condition Associated to Angiostrongylosis in Naturally Infected Dogs?
    Top Companion Anim Med. 2021 Jan 20:100513. doi: 10.1016/j.tcam.2021.100513.
    PubMed    
    Abstract available

  91. LAMBERT M, Mendes-Ferreira P, Ghigna MR, LeRibeuz H, et al
    Kcnk3 Dysfunction Exaggerates The Development Of Pulmonary Hypertension Induced By Left Ventricular Pressure Overload.
    Cardiovasc Res. 2021 Jan 23. pii: 6105230. doi: 10.1093.
    PubMed    
    Abstract available

  92. SIEFKES HM, Lakshminrusimha S
    Management of systemic hypotension in term infants with persistent pulmonary hypertension of the newborn: an illustrated review.
    Arch Dis Child Fetal Neonatal Ed. 2021 Jan 21. pii: archdischild-2020-319705.
    PubMed    
    Abstract available

  93. ARVANITAKI A, Giannakoulas G, Triantafyllidou E, Feloukidis C, et al
    Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study.
    Respir Res. 2021;22:27.
    PubMed    
    Abstract available

  94. SONNWEBER T, Schneider EM, Nairz M, Theurl I, et al
    Risk assessment in precapillary pulmonary hypertension: a comparative analysis.
    Respir Res. 2021;22:28.
    PubMed    
    Abstract available

  95. VERMA S, Lumba R, Kazmi SH, Vaz MJ, et al
    Effects of Inhaled Iloprost for the Management of Persistent Pulmonary Hypertension of the Newborn.
    Am J Perinatol. 2021 Jan 21. doi: 10.1055/s-0040-1722653.
    PubMed    
    Abstract available

  96. KINOSHITA H, Aoki T, Motoki H, Wakita T, et al
    Patient Journey and Disease-Related Burden in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension: A Mixed Methods Study.
    Value Health Reg Issues. 2021;24:17-23.
    PubMed    
    Abstract available

  97. CAO J, Luo JY, Wu D, Zhao Q, et al
    [Effect and mechanism of vascular endothelial growth factor-A on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension].
    Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:103-110.
    PubMed    
    Abstract available

  98. XING HQ, Gong JN, Chen BX, Guo XJ, et al
    Comparison of (68)Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardial fibrosis in a patient with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2021 Jan 20. pii: 10.1007/s12350-020-02517.
    PubMed    


  99. SAVOIA M, Morassutti FR, Castriotta L, Pavoni D, et al
    Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.
    Eur J Pediatr. 2021 Jan 21. pii: 10.1007/s00431-021-03954.
    PubMed    
    Abstract available

  100. BANASZKIEWICZ M, Pietrasik A, Florczyk M, Kedzierski P, et al
    Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  101. SHOWALTER K, Ma X, Pinheiro L, Sobol I, et al
    Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study.
    Semin Arthritis Rheum. 2021;51:324-330.
    PubMed    
    Abstract available

  102. GHOFRANI HA, D'Armini AM, Kim NH, Mayer E, et al
    Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension.
    Respir Med. 2021;177:106293.
    PubMed    
    Abstract available

  103. KHAUND BORKOTOKY R, Banerjee Barua P, Paul SP, Heaton PA, et al
    COVID-19-related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.
    Pediatr Infect Dis J. 2021 Jan 12. pii: 00006454-900000000-95900.
    PubMed    
    Abstract available

  104. WIEDENROTH CB, Guth S, Kriechbaum SD, Breithecker A, et al
    Balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension: recent advances and future perspectives.
    Kardiol Pol. 2021 Jan 18. doi: 10.33963/KP.15760.
    PubMed    
    Abstract available

  105. PASQUALETTO MC, Sorbo MD, Vitiello M, Ferrara C, et al
    Pulmonary Hypertension in COVID-19 Pneumoniae: It Is Not Always as It Seems.
    Eur J Case Rep Intern Med. 2020;7:002160.
    PubMed    
    Abstract available

  106. LEBER L, Beaudet A, Muller A
    Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review.
    Pulm Circ. 2021;11:2045894020977300.
    PubMed    
    Abstract available

  107. KJELLSTROM B, Ryftenius H, Landenfelt-Gestre LL, Ivarsson B, et al
    Outpatient specialist clinics for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the Nordic countries.
    Pulm Circ. 2020;10:2045894019897499.
    PubMed    
    Abstract available

  108. MURATA M
    Clinical Significance of Right Ventricular Function in Pulmonary Hypertension.
    Keio J Med. 2021 Jan 16. doi: 10.2302/kjm.2020-0015.
    PubMed    
    Abstract available

  109. REES S, Tahir M, Ahmad SJ, Subkovas E, et al
    Rare case of right ventricular dilatation associated with anomalous pulmonary venous drainage, sinus venosus atrial septal defect and persistent left superior vena cava.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  110. BRITTAIN EL
    Shuttling toward Improved Clinic-based Assessment of Exercise Capacity in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2021;18:26-27.
    PubMed    


  111. YAO L, Yang YX, Cao H, Ren HH, et al
    Osthole attenuates pulmonary arterial hypertension by the regulation of sphingosine 1-phosphate in rats.
    Chin J Nat Med. 2020;18:308-320.
    PubMed    
    Abstract available

  112. MOINZADEH P, Kuhr K, Siegert E, Mueller-Ladner U, et al
    Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets.
    Rheumatology (Oxford). 2020;59:3380-3389.
    PubMed    
    Abstract available

  113. BOATENG E, Krauss-Etschmann S
    miRNAs in Lung Development and Diseases.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  114. BARTLEY BL, Schwartz CE, Stark RB, Georgiopoulos AM, et al
    Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists.
    BMC Pulm Med. 2020;20:58.
    PubMed    
    Abstract available

  115. FRETHEIM H, Halse AK, Seip M, Bitter H, et al
    Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort.
    Rheumatology (Oxford). 2020;59:2920-2929.
    PubMed    
    Abstract available

  116. HEIWEGEN K, van Rooij IALM, van Heijst A, de Blaauw I, et al
    Surgical Complications in Children with CDH: A Multivariate Analysis.
    World J Surg. 2020;44:2042-2048.
    PubMed    
    Abstract available

  117. JONAS K, Kopec G
    A challenging phenotype of pulmonary arterial hypertension.
    Pol Arch Intern Med. 2020;130:85-86.
    PubMed    


  118. MIYAGAWA T, Taniguchi T, Saigusa R, Fukayama M, et al
    Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Rheumatology (Oxford). 2020;59:2005-2015.
    PubMed    
    Abstract available

  119. MOTTA I, Mancarella M, Marcon A, Vicenzi M, et al
    Management of age-associated medical complications in patients with beta-thalassemia.
    Expert Rev Hematol. 2020;13:85-94.
    PubMed    
    Abstract available

  120. MUNDO W, Wolfson G, Moore LG, Houck JA, et al
    Hypoxia-induced inhibition of mTORC1 activity in the developing lung: a possible mechanism for the developmental programming of pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jan 8. doi: 10.1152/ajpheart.00520.2020.
    PubMed    
    Abstract available

  121. INAGAKI T, Pearson JT, Tsuchimochi H, Schwenke DO, et al
    Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
    Am J Physiol Heart Circ Physiol. 2021 Jan 22. doi: 10.1152/ajpheart.00327.2020.
    PubMed    
    Abstract available

  122. SHRESTHA AK, Menon RT, El-Saie A, Barrios R, et al
    Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L981-L996.
    PubMed    
    Abstract available

  123. HUANG SK
    Knocking Out Smoking and Pulmonary Hypertension with a K().
    Am J Respir Crit Care Med. 2020 Dec 23. doi: 10.1164/rccm.202011-4121.
    PubMed    


  124. HU L, Wang J, Huang H, Yu Y, et al
    YTHDF1 Regulates Pulmonary Hypertension Through Translational Control of MAGED1.
    Am J Respir Crit Care Med. 2021 Jan 19. doi: 10.1164/rccm.202009-3419.
    PubMed    
    Abstract available

  125. NICHOLS L
    Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Ann Intern Med. 2021;174:139.
    PubMed    


  126. LAX SF, Skok K, Zechner PM, Trauner M, et al
    Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Ann Intern Med. 2021;174:139-140.
    PubMed    


  127. KOVACS G, Zeder K, Rosenstock P, Avian A, et al
    Clinical impact of the new definition of pre-capillary pulmonary hypertension.
    Chest. 2021 Jan 5. pii: S0012-3692(20)35526-4. doi: 10.1016/j.chest.2020.
    PubMed    


  128. ZIREK F, Akova BS, Ozcan G, Fitoz S, et al
    A 2-Year-Old Boy With Hypoxemia, Pulmonary Hypertension, and Digital Clubbing.
    Chest. 2021;159:e45-e48.
    PubMed    
    Abstract available

  129. REMY-JARDIN M, Ryerson CJ, Schiebler ML, Leung ANC, et al
    Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  130. SWINNEN K, Bijnens E, Casas L, Nawrot TS, et al
    Residential air pollution increases the risk for persistent pulmonary hypertension after pulmonary endarterectomy.
    Eur Respir J. 2021 Jan 21. pii: 13993003.02680-2020.
    PubMed    


  131. ABDELKREEM E, Mahmoud SM, Aboelez MO, Abd El Aal M, et al
    Nebulized Magnesium Sulfate for Treatment of Persistent Pulmonary Hypertension of Newborn: A Pilot Randomized Controlled Trial.
    Indian J Pediatr. 2021 Jan 8. pii: 10.1007/s12098-020-03643.
    PubMed    
    Abstract available

  132. HO JE, Lewis GD
    Reply: Does PAP/CO Ratio Have a Linear Relationship?
    J Am Coll Cardiol. 2020;75:2647.
    PubMed    


  133. LO RUSSO G, Maragna R, Trombara F, Agostoni P, et al
    Does PAP/CO Ratio Have a Linear Relationship?
    J Am Coll Cardiol. 2020;75:2646.
    PubMed    


  134. HOEPER MM
    Pulmonary Artery Denervation: The New Kid on the Block?
    J Am Coll Cardiol. 2020;76:927-929.
    PubMed    


  135. BIANCO JC, Stang MV, Denault AY, Marenchino RG, et al
    Acute Kidney Injury After Heart Transplant: The Importance of Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2020 Dec 13. pii: S1053-0770(20)31355.
    PubMed    
    Abstract available

  136. KRAKOWSKI JC, Arora H
    Con: General Anesthesia Is Not Superior to Regional Anesthesia for Patients With Pulmonary Hypertension Undergoing Noncardiac Surgery.
    J Cardiothorac Vasc Anesth. 2021 Jan 6. pii: S1053-0770(21)00004.
    PubMed    


  137. HOPPER RK, Ivy DD, Yung D, Mullen MP, et al
    Pharmacokinetics of Oral Treprostinil in Children with Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Apr 16. doi: 10.1097/FJC.0000000000000842.
    PubMed    
    Abstract available

  138. GAO X, Zhang Z, Li X, Wei Q, et al
    Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    J Cardiovasc Pharmacol. 2020;75:545-555.
    PubMed    
    Abstract available

  139. BADAGLIACCA R, Rischard F, Papa S, Kubba S, et al
    Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
    J Heart Lung Transplant. 2020;39:310-320.
    PubMed    
    Abstract available

  140. PRESTON IR, Burger CD, Bartolome S, Safdar Z, et al
    Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
    J Heart Lung Transplant. 2020;39:464-472.
    PubMed    
    Abstract available

  141. AGARWAL P, Shankaran S, Laptook AR, Chowdhury D, et al
    Outcomes of infants with hypoxic ischemic encephalopathy and persistent pulmonary hypertension of the newborn: results from three NICHD studies.
    J Perinatol. 2021 Jan 6. pii: 10.1038/s41372-020-00905.
    PubMed    
    Abstract available

  142. NELLIS JR, Haney JC, Turek JW
    Commentary: Repair or replace-Potts shunt versus lung transplantation for refractory pediatric pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33220.
    PubMed    


  143. BELLI E
    Commentary: Potts palliation for pulmonary hypertension: What's next?
    J Thorac Cardiovasc Surg. 2020 Dec 5. pii: S0022-5223(20)33226.
    PubMed    


  144. LANCASTER TS, Shahanavaz S, Balzer DT, Sweet SC, et al
    Midterm outcomes of the Potts shunt for pediatric pulmonary hypertension, with comparison to lung transplant.
    J Thorac Cardiovasc Surg. 2020 Dec 9. pii: S0022-5223(20)33316.
    PubMed    
    Abstract available

  145. WAXMAN A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, et al
    Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2008470.
    PubMed    
    Abstract available

  146. TAICHMAN DB
    Optimism for Interstitial Lung Disease-Associated Pulmonary Hypertension?
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2033181.
    PubMed    


  147. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    PubMed    


  148. SAHAY S, Tonelli AR, Selej M, Watson Z, et al
    Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.
    PLoS One. 2020;15:e0241504.
    PubMed    
    Abstract available

  149. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
    The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
    PLoS One. 2021;16:e0245752.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;